The effect of renal failure on 18F-FDG uptake: A theoretic assessment

Journal of Nuclear Medicine Technology

Volumn 36, Issue 4, 2008, Pages 200-202

  Laffon, Eric ^a,b,c,d   Cazeau, Anne Laure ^a   Monet, Antoine ^a   De Clermont, Henri ^a   Fernandez, Philippe ^a   Marthan, Roger ^b,c   Ducassou, Dominique ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^d HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

18F FDG kinetic modeling; 18F FDG PET radiation dose; Renal failure

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRACER;

ARTICLE; COMPARTMENT MODEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; GLUCOSE METABOLISM; INSULIN METABOLISM; KIDNEY FAILURE; KIDNEY FUNCTION; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOISOTOPE DECAY; TISSUE DISTRIBUTION;

COMPUTER SIMULATION; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KIDNEY; KIDNEY FAILURE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; RADIOPHARMACEUTICALS;

EID: 57449098237     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.107.049627     Document Type: Article

References (13)

1. 18F]fluoro-2-deoxy-D-glucose in tissues. Nucl Med Commun. 2004;25:851-854.
2. 18F-FDG in tissues. CR Biol. 2005;328:767-772.
3. ICRP publication 53: radiation dose to patients from radiopharmaceuticals (addendum 5). In: Annals of the ICRP. Oxford, U.K.: Pergamon Press; 2001:5-11.
4. Hays MT, Segall GM. A mathematical model for the distribution of fluorodeoxyglucose in humans. J Nucl Med. 1998;40:1358-1366.
5. 18F-FDG. J Nucl Med. 2002;43:210-214.
6. 18F-FDG PET/CT. J Nucl Med. 2006;47:885-895.
7. Shiozaki T, Sadato N, Senda M, et al. Noninvasive estimation of FDG input function for quantification of cerebral metabolic rate of glucose: optimization and multicenter evaluation. J Nucl Med. 2000;41:1612-1618.
8. Hunter GJ, Hamberg LM, Alpert NM, Choi NC, Fischman AJ. Simplified measurement of deoxyglucose utilization rate. J Nucl Med. 1996;37:950-955.
9. 18F-FDG kinetics and gene expression in giant cell tumors. J Nucl Med. 2004;45:1528-1535.
10. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest. 1981;67:563-568.
11. Minamimoto R, Takahashi N, Inoue T. FDG-PET of patients with suspected renal failure: standardized uptake values in normal tissues. Ann Nucl Med. 2007;21:217-222.
12. Bingham EM, Hopkins D, Smith D, et al. The role of insulin in human brain glucose metabolism. Diabetes. 2002;51:3384-3390.
13. Hasselbalch SG, Knudsen GM, Videbaek C, et al. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes. 1999;48:1915-1921.